Medifast (MED) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $10.70 --0%
EPS Growth %: -295.5%
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: -295.5%
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $0.34, $0.01 better than the analyst estimate of $0.33. Revenue for the quarter came in at $62.5 million versus the consensus estimate of $65.01 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
- Merck (MRK) PT Raised to $155 at Scotiabank
- Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
